The global anti-snore device market is projected to increase from USD 1.9 billion in 2026 to USD 3.6 billion by 2036, expanding at a 6.6% CAGR during the 2026–2036 forecast period. The market reached USD 1.8 billion in 2025, with an absolute opportunity of USD 1.7 billion expected between 2026 and 2036.
Demand is being supported by growing use of non-invasive devices in home settings, online access to sleep-care products, and greater attention to screening and follow-up for sleep-related breathing disorders. In April 2025, the American Academy of Dental Sleep Medicine (AADSM) updated its adult oral-appliance standards, reinforcing screening, treatment, and follow-up expectations for fitted oral devices.
Get Detailed Market Forecasts, Competitive Benchmarking, and Pricing Trends: https://www.factmr.com/connectus/sample?flag=S&rep_id=3546
Global Segment Leaders
- Mandibular Advancement Devices — 62.8% share: These devices lead the Product segment because they move the lower jaw forward and help keep the upper airway open during sleep.
- Obstructive Sleep Apnea — 74.1% share: OSA leads the Application segment because snoring can occur alongside partial airway obstruction, supporting oral-device use in selected cases.
- Home Care Settings — 68.5% share: Home care leads the End Use segment because anti-snore devices are worn nightly and many users manage therapy outside hospitals.
- Mechanical Airway Adjustment Technology — 55.9% share: This technology leads because jaw advancement and tongue positioning provide mechanisms that clinicians can explain and adjust.
- Custom Fit Oral Devices — 47.6% share: Custom-fit devices lead the Formulation segment because comfort and retention influence nightly adherence, while patient-specific molding supports prescription routes.
- Online Retail — 63.4% share: Online retail leads the Distribution Channel segment as users compare product claims, clearance status, fitting instructions, and device information before purchase.
Fact.MR Principal Consultant Shambhu Nath Jha stated, “Anti-snore devices are becoming a comfort and adherence category that reaches beyond simple accessories.” He added that demand remains linked to dental fit, credible device claims, home-use guidance, adjustment support, and follow-up pathways.
Country-Level Performance
- Germany — 7.6% CAGR: The Robert Koch Institute reported in June 2026 that 12.6% of adults in its 2024 panel had both sleep-onset and sleep-maintenance problems. Fact.MR links growing awareness of sleep-related concerns and online health purchasing with demand for snoring-management solutions.
- Brazil — 6.9% CAGR: IBGE reported in July 2026 that 90.5% of Brazil’s population aged 10 and older used the internet in 2025. The report links broad internet access with digital discovery of mouthpieces, nasal devices, and other snoring-management products.
- USA — 6.3% CAGR: The CDC’s National Center for Health Statistics reported in April 2026 that 30.5% of U.S. adults slept less than seven hours in 2024. Fact.MR identifies short-sleep prevalence, home testing, and established regulatory pathways for oral sleep appliances as factors supporting the market.
- UK — 5.6% CAGR: NHS England reported in January 2026 that 66% of adults in England were overweight or living with obesity in 2024. The report links weight-related sleep-health risks with greater attention to snoring and sleep-apnoea assessment.
- Japan — 5.0% CAGR: Japan’s Statistics Bureau reported in April 2025 that the population aged 65 and over reached 36.24 million in 2024. Fact.MR identifies ageing, e-commerce access, and regulated device pathways as factors shaping market demand.
Regional Context
Germany records the highest CAGR among the five countries profiled at 7.6%. The report links its growth to sleep-problem awareness and online health purchasing, while dental and sleep-care pathways support professionally fitted oral appliances.
Brazil and the United States form the middle growth group, with CAGRs of 6.9% and 6.3%, respectively. Brazil’s expanding internet access supports online product discovery, while the U.S. combines high short-sleep prevalence with home sleep testing and established dental sleep-care pathways.
The UK and Japan record lower CAGRs of 5.6% and 5.0%. In the UK, obesity-linked sleep-health risks and diagnostic demand support market activity. Japan’s ageing population, e-commerce access, and professionally supervised oral-appliance pathways shape demand.
The full report covers North America, Latin America, Western Europe, Eastern Europe, East Asia, South Asia & Pacific, and Middle East & Africa, with 25+ countries included in the broader analysis and five countries specifically profiled in the country comparison.
Competitive Landscape
The key companies profiled in the anti-snore device market are ResMed, Philips Healthcare, Apnea Sciences Corporation, SomnoMed, Tomed GmbH, The Pure Sleep Company, and Fisher & Paykel Healthcare.
The competitive landscape covers oral appliances, snoring devices, diagnostics, PAP therapy, and related sleep-disordered breathing products. SomnoMed focuses on oral appliance therapy and compliance monitoring, while Apnea Sciences offers SnoreRx and ApneaRx oral appliances. PureSleep provides consumer anti-snoring mouthpieces, and Tomed supplies SomnoGuard devices and positional products.
A recent development cited by Fact.MR is Fisher & Paykel Healthcare’s May 2026 report, which stated that Homecare revenue, including products used for OSA and home respiratory support, reached NZD 802.7 million in FY2026.
Related Reports:
https://www.openpr.com/news/4639012/party-supply-rental-market-valued-at-usd-20-9-bn-in-2026-germany
https://www.openpr.com/news/4639142/office-real-estate-market-adds-usd-1-224-2-bn-by-2036-usa-grows
About Fact.MR
Factmr is a leading provider of market research and consulting services, offering syndicated and customized research across industries including Healthcare, Consumer Goods, and Technology.
